SureTrader
Home > Boards > US Listed > Biotechs > Celsion Corporation (CLSN)

And no doubt a lot of those short

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
badslinke Member Profile
 
Followed By 0
Posts 69
Boards Moderated 0
Alias Born 10/15/12
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/4/2018 10:24:33 AM
Celsion Announces FDA Clearance of the OVATION II Study for the Evaluation of GEN-1 Immunotherapy to Treat Newly Diagnosed... "GlobeNewswire Inc." - 1/4/2018 8:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 12/11/2017 6:01:56 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 12/8/2017 5:14:26 PM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 12/1/2017 5:18:33 PM
Recent Analysis Shows Amazon, Oracle, Whiting Petroleum, Mondelez International, Synergy Resources, and Celsion Market Influe... "GlobeNewswire Inc." - 11/27/2017 8:25:00 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 11/22/2017 4:49:27 PM
Celsion Announces Publication of the Study of ThermoDox® + Ultrasound, “TARDOX Study Protocol” in the Journal of Therape... "GlobeNewswire Inc." - 11/20/2017 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/14/2017 8:44:59 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2017 8:10:50 AM
Celsion Corporation Reports Third Quarter 2017 Financial Results and Provides Business Update "GlobeNewswire Inc." - 11/14/2017 8:00:00 AM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 11/14/2017 6:08:35 AM
CORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnose... "GlobeNewswire Inc." - 11/13/2017 7:23:14 PM
Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer "GlobeNewswire Inc." - 11/13/2017 5:15:47 PM
Celsion Corporation to Hold Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017 "GlobeNewswire Inc." - 11/7/2017 9:00:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 11/6/2017 5:01:33 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 11/6/2017 4:59:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/31/2017 5:01:53 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/30/2017 9:02:20 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/27/2017 9:11:58 AM
Celsion Corporation Announces Pricing of Underwritten Offering of Common Stock and Warrants to Purchase Common Stock "GlobeNewswire Inc." - 10/27/2017 9:10:00 AM
Celsion Provides Summary of Research and Development Day Held on October 12, 2017 "GlobeNewswire Inc." - 10/18/2017 8:30:00 AM
Celsion Provides Summary of Research and Development Day Held on Thursday, October 12, 2017 "GlobeNewswire Inc." - 10/17/2017 8:30:00 AM
Celsion Announces Publication of the HEAT Study Manuscript in the High Impact Journal, Clinical Cancer Research "GlobeNewswire Inc." - 10/16/2017 8:30:00 AM
Celsion to Host Research and Development (R&D) Day on Thursday, October 12, 2017 "GlobeNewswire Inc." - 10/12/2017 11:03:31 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist